In terms of hair loss, the tests of most use are described on other
pages in this section of keratin.com. However, below is a list of
normal ranges for other blood tests in case you see them on your
test result charts.
Note; only the basic ranges are listed here and mostly refere
to adult normal ranges. Values for children may be significantly
different. Normal ranges will also be slightly different in different
laboratories as there is no calibration of the tests between different
labs.
| Analyte |
Specimen |
Normal Range Value |
| |
|
|
| Acidity (pH) |
S, P |
7.35 7.45 |
| Adrenocorticotropin (ACTH) |
P |
6.0 76.0 pg/ml |
| Alanine aminotransferase (ALT, SGPT) |
S |
|
| Female
|
|
7 30 U/L |
| Male
|
|
10 55 U/L |
| Albumin |
S |
3.1 4.3 g/dL |
| Alcohol (ethanol) |
S, P |
0 mg/dL (more than 0.1 mg/dL normally indicates
intoxication) |
| Aldolase |
S |
0 7 U/L |
| Aldosterone (adult) |
|
|
| Supine,
normal-sodium diet |
S, P |
2 9 ng/dL |
| Upright,
normal-sodium diet |
S, P |
2 5 times supine value with normal sodium diet
|
| Supine,
low-sodium diet |
S, P |
2 5 times supine value with normal sodium diet
|
| Alkaline phosphatase (adult) |
S |
|
| Female
|
|
30 100 U/L |
| Male
|
|
45 115 U/L |
| Alkaline phosphatase, heat fractionated |
S |
20 35% |
| Alpha-fetoprotein (nonmaternal) |
S |
< 12.8 IU/ml |
| Ammonia |
P |
12 48 ΅mol/L |
| Amylase |
S |
53 123 U/L |
| Amylase |
P |
43 115 U/L |
| Androstenedione (adult) |
S |
50 250 ng/dL |
| Angiotensin-converting enzyme |
S |
|
| Male
|
|
19 95 U/L |
| Female
|
|
19 79 U/L |
| Apolipoprotein |
S |
|
| Apolipoprotein A-1 |
|
119 240 mg/dL |
| Apolipoprotein B |
|
52 163 mg/dL |
| Apolipoprotein B:apolipoprotein A-1 ratio |
|
0.35 0.98 |
| Aspartate aminotransferase (AST, SGOT) |
S |
|
| Female
|
|
9 25 U/L |
| Male
|
|
10 40 U/L |
| Beta 2 microglobulin |
S, P |
1.2 2.8 mg/L |
| Bicarbonate (HCO3) |
WB, S |
22 26 meq/L |
| Bilirubin, direct |
S |
0.0 0.4 mg/dL |
| Bilirubin, total |
S |
0.0 1.0 mg/dL |
| C peptide (adult) |
S, P |
0.5 2.0 ng/ml |
| C-reactive protein |
S |
0.0 12.0 mg/L |
| CA 15-3 |
S |
0 30 U/ml |
| CA 19-9 |
S |
0 37 U/ml |
| CA 27,29S |
S |
0 32 U/ml |
| CA-125 |
S |
0 35 U/ml |
| Calcitonin |
S |
|
| Male
|
|
3 26 pg/ml |
| Female
|
|
2 17 pg/ml |
| Calcium |
S |
8.5 10.5 mg/dL |
| Calcium, ionized |
WB |
1.14 1.30 mmol/L |
| Carbon dioxide content, total |
P |
24 30 mmol/L |
| Carbon dioxide, partial pressure, arterial (PaCO2)
|
WB |
35 45 mm Hg |
| Carbon monoxide |
WB |
Less than 5% of total hemoglobin |
| Carboxyhemoglobin |
WB |
< 5% of total hemoglobin |
| Carcinoembryonic antigen (CEA) |
P, S |
0.0 3.4 ng/ml |
| Ceruloplasmin protein |
S |
27 50 mg/dL |
| Chloride |
P |
100 108 mmol/L |
| Cholesterol |
S |
|
| Desirable
|
|
< 200 mg/dL |
| Borderline
high |
|
200 239 mg/dL |
| High
|
|
> 239 mg/dL |
| Cortisol |
S |
|
| Fasting,
8 a.m.noon |
|
5 25 µg/dL |
| Noon8
p.m. |
|
5 15 µg/dL |
| 8
p.m.8 a.m. |
|
0 10 µg/dL |
| Creatine kinase (CK) |
S |
|
| Male
|
|
60 400 U/L |
| Female
|
|
40 150 U/L |
| Creatine kinase isoenzyme index |
S |
0 2.5% relative index |
| Creatine kinase isoenzymes, MB fraction |
S |
0 5 ng/ml |
| Creatinine |
P |
0.6 1.5 mg/dL |
| Dehydroepiandrosterone (DHEA) (adult) |
S |
|
| Male
|
|
180 1250 ng/dL |
| Female
|
|
130 980 ng/dL |
| Dehydroepiandrosterone (DHEA) sulfate (adult)
|
S |
|
| Male
|
|
10 619 mg/dL |
| Premenopausal
female |
|
12 535 mg/dL |
| Postmenopausal
female |
S |
30 260 mg/dL |
| Deoxycorticosterone (DOC) (adult) |
S |
2 19 ng/dL |
| 11-Deoxycortisol (adult) (8 a.m. sample) |
S |
12 158 ng/dL |
| 1,25-Dihydroxyvitamin D |
S |
18 62 pg/ml |
| Estradiol |
S, P |
|
| Menstruating
female follicular phase |
|
50 145 pg/ml |
| Menstruating
female midcycle peak |
|
112 443 pg/ml |
| Menstruating
female luteal phase |
|
50 241 pg/ml |
| Postmenopausal
female |
|
< 59 pg/ml |
| Male
|
|
< 50 pg/ml |
| Fatty acids, free (adult) |
S |
0.17 0.95 mmol/L |
| Follicle-stimulating hormone (FSH) |
S, P |
|
| Menstruating
female follicular phase |
|
3.0 20.0 U/L |
| Menstruating
female ovulatory phase |
|
9.0 26.0 U/L |
| Menstruating
female luteal phase |
|
1.0 12.0 U/L |
| Postmenopausal
female |
|
18.0 153.0 U/L |
| Male
|
|
1.0 12.0 U/L |
| Gastrin |
S |
< 100 ng/L |
| Globulin |
S |
2.6 4.1 g/dL |
| Glucagon |
P |
20 100 pg/ml |
| Glucose, fasting |
P |
70 110 mg/dL |
| gamma-Glutamyltransferase (CGT) |
S |
|
| Male
|
|
1 94 U/L |
| Female
|
|
1 70 U/L |
| Growth hormone (resting) |
S |
2 5 ng/ml |
| Hemoglobin A 1C |
WB |
3.8 6.4% |
| High-density lipoprotein cholesterol, as major
risk factor |
S |
< 35 mg/dL |
| Human chorionic gonadotropin (hCG) (nonpregnant
women) |
S |
< 5 mIU/ml |
| 17-Hydroxyprogesterone (adult) |
S |
|
| Male
|
|
5 250 ng/dL |
| Menstruating
female follicular phase |
|
20 100 ng/dL |
| Menstruating
female midcycle peak |
|
100 250 ng/dL |
| Menstruating
female luteal phase |
|
100 500 ng/dL |
| Menstruating
female postmenopausal |
|
< 70 ng/dL |
| 25-Hydroxyvitamin D |
S |
8 42 ng/ml |
| Insulin |
S, P |
2 20 µU/ml |
| Ketone (acetone) |
S |
Negative |
| Lactic acid |
P |
0.5 2.2 mmol/L |
| Lactate dehydrogenase (LDH) |
S |
110 210 U/L |
| Lactate dehydrogenase isoenzymes |
S |
|
| LD
1 |
|
16 29% |
| LD
2 |
|
30 41% |
| LD
3 |
|
15 24% |
| LD
4 |
|
6 13% |
| LD
5 |
|
5 29% |
| Total LDH (when isoenzymes determined) |
|
90 250 U/L |
| Lead |
S |
< 40 µg/dL |
| Lipase |
S |
3 19 U/dL |
| Lipoprotein(a) |
S |
0 30 mg/dL |
| Low-density
lipoprotein cholesterol |
S |
|
| Desirable
|
|
< 130 mg/dL |
| Borderline
high risk |
|
130 159 mg/dL |
| High
risk |
|
> 160 mg/dL |
| Luteinizing hormone (LH) |
S, P |
|
| Menstruating
female follicular phase |
|
2.0 15.0 U/L |
| Menstruating
female ovulatory phase |
|
22.0 105.0 U/L |